Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EZH2 | Q15910 | 8/20 | 0.50 |
| ▸ | HDAC6 | Q9UBN7 | 11/20 | 0.48 |
| ▸ | EZH1 | Q92800 | 6/20 | 0.46 |
| ▸ | EED | O75530 | 2/20 | 0.46 |
| ▸ | RBBP4 | Q09028 | 2/20 | 0.46 |
| ▸ | SUZ12 | Q15022 | 2/20 | 0.46 |
| ▸ | RBBP7 | Q16576 | 2/20 | 0.46 |
| ▸ | AEBP2 | Q6ZN18 | 2/20 | 0.46 |
| ▸ | HDAC1 | Q13547 | 5/20 | 0.44 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.43 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.43 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.43 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.43 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.43 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.43 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.43 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.43 |
| ▸ | PRMT3 | O60678 | 1/20 | 0.41 |
| ▸ | SETD7 | Q8WTS6 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2595145 | 0.86 | EZH2 (0.70) | EZH2HDAC6EZH1EEDRBBP4 | |
| SCHEMBL17970531 | 0.74 | EZH2 (0.80) | EZH2HDAC6EZH1EEDRBBP4 | |
| SCHEMBL2590359 | 0.74 | EZH2 (0.78) | EZH2HDAC6EZH1EEDRBBP4 | |
| SCHEMBL16116261 | 0.72 | EZH2 (0.51) | EZH2HDAC6EZH1EEDRBBP4 | |
| SCHEMBL12180731 | 0.72 | EZH2 (0.88) | EZH2HDAC6EZH1EEDRBBP4 | |
| Hydrochloric Acid SCHEMBL2590277 | 0.72 | EZH2 (0.87) | EZH2HDAC6EZH1EEDRBBP4 | |
| SCHEMBL12684034 | 0.70 | EZH2 (0.79) | EZH2HDAC6EZH1EEDRBBP4 | |
| SCHEMBL16115487 | 0.70 | EZH2 (0.51) | EZH2HDAC6EZH1EEDRBBP4 | |
| SCHEMBL16115789 | 0.69 | RET (0.48) | HDAC6 | |
| SCHEMBL12180694 | 0.69 | EZH2 (0.79) | EZH2EZH1EEDRBBP4SUZ12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9018382-B2 | Indazoles | GLAXOSMITHKLINE LLC (US) | 2015-04-28 | — | — | US | disclosed |
| EP-2566328-B1 | INDAZOLES | GLAXOSMITHKLINE LLC (US) | 2015-03-04 | — | — | EP | disclosed |
| US-20140350013-A1 | INDAZOLES | GLAXOSMITHKLINE LLC | 2014-11-27 | — | — | US | disclosed |
| US-8846935-B2 | Indazoles | GLAXOSMITHKLINE LLC (US) | 2014-09-30 | — | — | US | disclosed |
| EP-2566328-A1 | INDAZOLES | GlaxoSmithKline LLC (US) | 2013-03-13 | — | — | EP | disclosed |
| US-20130053383-A1 | INDAZOLES | GLAXOSMITHKLINE LLC | 2013-02-28 | — | — | US | disclosed |
| WO-2011140325-A1 | INDAZOLES | GLAXOSMITHKLINE LLC (US) | 2011-11-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130053383-A1 | INDAZOLES | IDH3A, CYP3A7, IDH3B | EZH2 1599/4885HDAC6 212/4885EZH1 1398/4885 |
| US-20140350013-A1 | INDAZOLES | IDH3A, CYP3A7, IDH3B | EZH2 1599/4885HDAC6 212/4885EZH1 1398/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.